bioAffinity Technologies (BIAF) Non Operating Income (2022 - 2026)
bioAffinity Technologies (BIAF) posted quarterly Non Operating Income of -$13634.0 for Q1 2026, up 44.54% YoY from -$9432.8 in Q1 2025, and down 609.11% sequentially from $2678.0 in Q4 2025.
bioAffinity Technologies (BIAF) Non Operating Income (2022 - 2026) Analysis & Trends
bioAffinity Technologies has disclosed Non Operating Income across 5 years of filings, most recently posting -$13634.0 for Q1 2026.
- In Q1 2026, Non Operating Income rose 44.54% year-over-year to -$13634.0; the TTM figure through Mar 2026 stood at -$4.3 million (down 4855.97% YoY), while the FY2025 annual figure was -$4.3 million, down 5644.49% from the prior year.
- Non Operating Income declined to -$13634.0 in Q1 2026, from $2678.0 in the prior quarter.
- Over the last five years, Non Operating Income for BIAF reached as high as $42764.0 in Q2 2023 and fell as low as -$2.8 million in Q3 2025.
- The 5-year median for Non Operating Income is -$18703.0 (2024), against an average of -$390812.5.
- The widest YoY moves for Non Operating Income: up 113.16% in 2025, down 11183.35% in 2025.
- A 5-year view of Non Operating Income shows it stood at -$1.1 million in 2022, then jumped by 97.52% to -$28466.0 in 2023, then advanced by 28.53% to -$20344.0 in 2024, then soared by 113.16% to $2678.0 in 2025, then sank by 609.11% to -$13634.0 in 2026.
- According to Business Quant data, Non Operating Income over the past three periods registered -$13634.0, $2678.0, and -$2.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | 1.00 Mn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | -9.00 Mn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | -73.00 Mn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | - |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | 9.60 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 21.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | -4.00 Mn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | -52.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 7.33 Mn |
| 10 | bioAffinity Technologies | 3.78 Mn | 675,591.56 | - | -13,634.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13,634.00 |
| Dec 31, 2025 | 2,678.00 |
| Sep 30, 2025 | -2.76 Mn |
| Jun 30, 2025 | -1.52 Mn |
| Mar 31, 2025 | -24,583.00 |
| Dec 31, 2024 | -20,344.00 |
| Sep 30, 2024 | -24,417.00 |
| Jun 30, 2024 | -17,062.00 |
| Mar 31, 2024 | -12,913.00 |
| Dec 31, 2023 | -28,466.00 |
| Sep 30, 2023 | 5,914.00 |
| Jun 30, 2023 | 42,764.00 |
| Mar 31, 2023 | 36,999.00 |
| Mar 31, 2022 | -1.15 Mn |